You're contacting media contact of this press release

Title: Diopter Technologies to Present Breakthrough Bioshare Polymer Amniotic Membrane Technology at MedDevice Boston 2025

Cambridge, MA, United States, 1st Oct 2025 - Diopter Technologies, a medical device innovator specializing in ophthalmic solutions, today announced it will present a scientific poster at MedDevice Boston, taking place September 30 - October 1, 2025, at the Boston Convention & Exhibition Center. The presentation will showcase the company's Bioshare polymer amniotic membrane dissolving device, a novel technology designed to treat ocular wounds and injuries.The Bioshare device represents a significant advancement in ocular surface repair, utilizing biocompatible polymer technology combined with amniotic membrane properties to promote healing while eliminating the need for surgical removal. The dissolving mechanism offers clinicians and patients a streamlined treatment approach for corneal injuries, chemical burns, surgical wounds, and other ocular surface disorders.Addressing a Significant Market OpportunityThe global ophthalmic devices market continues to experience robust growth, driven by increasing prevalence of eye injuries, rising surgical volumes, and an aging population. The corneal repair and regeneration segment represents a particularly compelling opportunity, with the global corneal implants and devices market projected to reach several billion dollars within the next decade.Ocular trauma affects millions of patients annually worldwide, with corneal injuries representing one of the most common forms of eye trauma. In the United States alone, approximately 2.4 million eye injuries occur each year, with many requiring advanced therapeutic interventions. The current standard of care often involves sutures, adhesives, or traditional amniotic membrane grafts that require specialized surgical expertise and follow-up procedures."The ophthalmic device market is exp...

This press release is issued by King Newswire